Tiziana Life Sciences annual debt-to-equity ratio
2016
2018
2019
2020
2022
2023
2024
2025
Tiziana Life Sciences Debt-to-Equity Ratio Growth & History (TLSA)
Tiziana Life Sciences's debt-to-equity ratio was 8.77 for fiscal 2025.
View full Tiziana Life Sciences company overviewTiziana Life Sciences annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 8.77 | 8.74 | +32461.97% |
| 2024 | 2024-12-31 | 0.03 | 0.00 | +8.04% |
| 2023 | 2023-12-31 | 0.02 | 0.02 | +275.28% |
| 2022 | 2022-12-31 | 0.01 | — | — |
| 2020 | 2020-12-31 | 0.01 | −0.01 | −30.47% |
| 2019 | 2019-12-31 | 0.02 | −0.56 | −96.52% |
| 2018 | 2018-12-31 | 0.58 | — | — |
| 2016 | 2016-12-31 | 0.07 | — | — |
Tiziana Life Sciences quarterly debt-to-equity ratio
Q4.18
Q4.19
Q4.20
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 8.77 | 8.74 | +32461.97% |
| Q4 2024 | 2024-12-31 | 0.03 | 0.00 | +8.04% |
| Q4 2023 | 2023-12-31 | 0.02 | 0.02 | +275.28% |
| Q4 2022 | 2022-12-31 | 0.01 | — | — |
| Q4 2020 | 2020-12-31 | 0.01 | −0.01 | −30.47% |
| Q4 2019 | 2019-12-31 | 0.02 | −0.56 | −96.52% |
| Q4 2018 | 2018-12-31 | 0.58 | — | — |
Tiziana Life Sciences debt-to-equity ratio trends
Over the last five fiscal years, Tiziana Life Sciences's debt-to-equity ratio increased from 0.01 to 8.77, a change of 8.76. The latest reported quarter, Q4 2025, shows 8.77.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tiziana Life Sciences source filings ↗